… countries.Less than 25% of low income countries have human papillomavirus vaccination as
… Most gaps in the introduction and coverage of human papillomavirus vaccine are in regions …

… , especially in developing countries. Three HPV … vaccination strategies in any country should
be temporarily postponed until all countries have been able to introduce HPV vaccination in …

… experiences in 45 LMICs and what works for HPV vaccination introduction. Methods …
countries and projects and sufficient lessons have been learnt for countries to deliver HPV vaccine …

… GSK acquired the right to develop its HPV vaccine through an agreement with MedImmune,
LLC (Gaithersburg, MD, USA), which obtained the right to HPV vaccine development in …

… However, in most highly developed countries, vaccine coverage has not reached effective
… The role of human papillomavirus vaccines in cervical cancer: prevention and treatment. Crit …

… whether the vaccine is introduced in developing countries. A course of HPV vaccination
costs on average U240. In settings where money is limited and HPV vaccination competes for …

… on HPV vaccine introduction in developing and developed countries indicate that HPV vaccines
… first educated about safety and efficacy, and vaccines are supported by health providers. …

… of ICC make the following up of ICC as an endpoint for vaccine evaluation difficult. Moreover…
the effectiveness of HPV vaccine in preventing ICC. In the developed countries, it will take …

… induced protection are broadly in line with base case results from other published models
of human papillomavirus vaccination in developed countries.Our findings are likely to be more …

… The HPV vaccine uptake rates in Canada appear to be much lower than in many other
developed countries, which have reported coverage rates of > 70%.[43] The reasons for this …